Several months of preparations have resulted in the construction of a special, enclosed zone within the warehouse, featuring independent ventilation and air conditioning, elevated cleanliness standards, and specialized equipment that allows for the application of batch numbers and dates on products. During the preparations for the launch of the facility at Damco, the rooms and equipment were qualified and validated, all critical process points were analyzed, and a quality assurance system compliant with GMP standards was implemented. An inspection conducted at the production site by an inspector from the Main Pharmaceutical Inspectorate confirmed that Damco meets the conditions described by pharmaceutical law. The company’s permit is expected to be issued at the beginning of September. This will allow for the launch of production processes: procurement of materials, procurement of products, control activities related to supervising individual production operations, storage, and distribution. Thanks to this investment and the permit to be issued by the Main Pharmaceutical Inspector, Damco is able to provide co-packing services: packing, repacking, labeling, and marking of outer packaging for pharmaceutical and veterinary products.
– The investment, although very costly, will allow us to achieve a competitive advantage and will make our services for the pharmaceutical sector comprehensive. There are few logistics operators in the country that have managed to meet the high standards of GMP. It is all the more pleasing that Damco is among them – Andrzej Lada-Kubala, Branch Manager at Damco.